Applications are currently being accepted for the DayOne Accelerator Program for Healthtech Startups 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About DayOne Accelerator Program for Healthtech Startups
The DayOne Accelerator is a 3-month hybrid program designed to support international, high potential, early-stage ventures at the intersection of healthtech with pharma R&D, to refine their value proposition, connect with key industry players, and accelerate their growth. The top startups in each cohort have the chance to get long-term support, space and funding. The Accelerator is based in Basel, Switzerland, Europe’s leading life science innovation hub.
Benefits of DayOne Accelerator Program for Healthtech Startups
- Gain unparalleled access to pharma industry experts and key players in the Basel Area
- Develop or refine your pharma-specific value proposition with hands-on mentorship
- Tap into Basel’s world-class life sciences ecosystem – home to global pharma leaders
- Potential to get access to the post-accelerator program, including CHF 50,000 in non-dilutive funding, up to CHF 50,000 in personalized support and 12 months’ office space
- Stay independent: our accelerator is equity-free and fee-free
DayOne Accelerator Program for Healthtech Startups Requirements
The DayOne Accelerator is built for founders who are serious about breaking into pharma:
- Healthtech and techbio startups enabling pharma R&D
- Pre-Seed to Series A stage, with less than $10M of dilutive funds raised to date
- Startups aiming to collaborate or partner with pharma companies
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
31 May, 2026
Opportunity Application
View details of
DayOne Accelerator Program for Healthtech Startups
Apply for DayOne Accelerator Program for Healthtech Startups
🔍
